Penglei Wang Selected Research

purpurogallin

1/2019

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Penglei Wang Research Topics

Disease

6	Neoplasms (Cancer) 09/2021 - 01/2017
4	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2017
1	Melanoma (Melanoma, Malignant) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 10/2019
1	Inflammation (Inflammations) 01/2019
1	Carcinogenesis 01/2017
1	Esophagitis 01/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
1	Pharmaceutical PreparationsIBA 09/2021
1	periplogeninIBA 01/2021
1	honokiolIBA 01/2020
1	Keratin-18 (Keratin 18)IBA 01/2020
1	snake venom protein C activatorIBA 10/2019
1	Methylnitronitrosoguanidine (MNNG)IBA 10/2019
1	Proteolysis Targeting ChimeraIBA 10/2019
1	xanthohumolIBA 01/2019
1	FlavonoidsIBA 01/2019
1	purpurogallinIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	MAP Kinase Kinase 1IBA 01/2019
1	PolyaminesIBA 01/2017
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Eflornithine (Ornidyl)FDA Link 01/2017

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2017